To purchase hard copies of this book, please email:
orders@intechopen.com
By only printing on demand InTech ensures our carbon footprint is kept to a minimum.
The data below shows the environmental impact of printing one single book:
79.65 kg wood
4.28 g CO2
72.32 ml Water
Share this page
Understanding Tuberculosis - Global Experiences and Innovative Approaches to the Diagnosis
Edited by Pere-Joan Cardona, ISBN 978-953-307-938-7, Hard cover, 552 pages, Publisher: InTech, Published: February 15, 2012 under CC BY 3.0 license, in subject Infectious Diseases
DOI: 10.5772/1483
Mycobacterium tuberculosis is a disease that is transmitted through aerosol. This is the reason why it is estimated that a third of humankind is already infected by Mycobacterium tuberculosis. The vast majority of the infected do not know about their status. Mycobacterium tuberculosis is a silent pathogen, causing no symptomatology at all during the infection. In addition, infected people cannot cause further infections. Unfortunately, an estimated 10 per cent of the infected population has the probability to develop the disease, making it very difficult to eradicate. Once in this stage, the bacilli can be transmitted to other persons and the development of clinical symptoms is very progressive. Therefore the diagnosis, especially the discrimination between infection and disease, is a real challenge. In this book, we present the experience of worldwide specialists on the diagnosis, along with its lights and shadows.
This book is indexed in:
Book contents
- Chapter 1Clinical Laboratory Diagnostics for Mycobacterium tuberculosis
- Chapter 2Laboratory Diagnosis of Latent and Active Tuberculosis Infections in Trinidad & Tobago and Determination of Drug Susceptibility Profile of Tuberculosis Isolates in the Caribbean
- Chapter 3Tuberculosis is Still a Major Challenge in Africa
- Chapter 4Tuberculosis in Saudi Arabia
- Chapter 5Diagnosis of Mycobacterium tuberculosis
- Chapter 6Diagnosis of Smear-Negative Pulmonary Tuberculosis in Low-Income Countries: Current Evidence in Sub-Saharan Africa with Special Focus on HIV Infection or AIDS
- Chapter 7Immunologic Diagnosis of Neurotuberculosis
- Chapter 8Diagnostic Methods for Mycobacterium tuberculosis and Challenges in Its Detection in India
- Chapter 9Management of TB in HIV Subjects, the Experience in Thailand
- Chapter 10Mycobacterium tuberculosis: Biorisk, Biosafety and Biocontainment
- Chapter 11New Diagnostics for Mycobacterium tuberculosis
- Chapter 12Nanodiagnostics for Tuberculosis
- Chapter 13Sputum Smear Microscopy for Tuberculosis: Evaluation of Autofocus Functions and Automatic Identification of Tuberculosis Mycobacterium
- Chapter 14The Use of Phage for Detection, Antibiotic Sensitivity Testing and Enumeration
- Chapter 15Molecular Imaging in TB: From the Bench to the Clinic
- Chapter 16Data Mining Techniques in the Diagnosis of Tuberculosis
- Chapter 17Immunological Diagnosis of Active and Latent TB
- Chapter 18Immune Diagnosis of Tuberculosis Through Novel Technologies
- Chapter 19Exosomes: New Tuberculosis Biomarkers – Prospects From the Bench to the Clinic
- Chapter 20Molecular Techniques for Identification of Species of the Mycobacterium tuberculosis Complex: The use of Multiplex PCR and an Adapted HPLC Method for Identification of Mycobacterium bovis and Diagnosis of Bovine Tuberculosis
- Chapter 21Survey and Molecular Characterization of Drug- Resistant M. tuberculosis Clinical Isolates from Zunyi, Guizhou Province of China
- Chapter 22Molecular Biological Techniques for Detection of Multidrug Resistant Tuberculosis (MDR) and Extremely Drug Resistant Tuberculosis (XDR) in Clinical Isolates of Mycobacterium tuberculosis
- Chapter 23Detection of Mycobacterium tuberculosis and Drug Resistance: Opportunies and Challenges in Morocco
- Chapter 24Pattern of Circulating Mycobacterium tuberculosis Strains in Sri Lanka
- Chapter 25Health Interventions to Improve the Medication Efficacy in Tuberculosis Treatment
